Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Teclison Ltd.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Jiangsu HengRui Medicine Co., Ltd.
Rezolute
Exelixis
Institute for Clinical and Experimental Medicine
Novartis
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
Fundación de investigación HM
RayzeBio, Inc.
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
RayzeBio, Inc.
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Grupo Espanol de Tumores Neuroendocrinos
University of Michigan Rogel Cancer Center
Emory University
Cedars-Sinai Medical Center
Tata Memorial Hospital
University of Utah
University of Alberta
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Chimeric Therapeutics
SAPU NANO (US) LLC
Barbara Ann Karmanos Cancer Institute
Guerbet
Shanghai Chest Hospital
Mayo Clinic
Shanghai Zhongshan Hospital
Vanderbilt-Ingram Cancer Center
ITM Solucin GmbH
University of Miami
Washington University School of Medicine
Tanabe Pharma America, Inc.
Abramson Cancer Center at Penn Medicine